ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer. (2017). Biomedical Research and Therapy, 4(S), S33. https://doi.org/10.15419/bmrat.v4iS.243